Jason De Melo
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 4
-
- Ubiquitin and proteasome pathways 5
- PI3K/AKT/mTOR signaling in cancer 4
- Renal and related cancers 2
- Protein Degradation and Inhibitors 2
-
- Cancer Cells and Metastasis 2
-
- Hippo pathway signaling and YAP/TAZ 2
-
- Prostate Cancer Treatment and Research 3
- Co-authors
- Damu TangNicholas WongCorey LourencoLinda Z. PennManpreet KalkatDiana ResetcaWilliam B. TuJudy Yan
- Partner nations
- CanadaUnited StatesChina
In The Last Decade
Jason De Melo
20 papers receiving 843 citations
Peers
Comparison fields: 5 of 75
- Cancer Research 311
- Molecular Biology 658
- Oncology 231
- Cell Biology 58
- Genetics 33
Countries citing papers authored by Jason De Melo
This map shows the geographic impact of Jason De Melo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason De Melo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason De Melo more than expected).
Fields of papers citing papers by Jason De Melo
This network shows the impact of papers produced by Jason De Melo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason De Melo. The network helps show where Jason De Melo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jason De Melo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 17 | |
| 2 | 2019 | 2 | |
| 3 | 2018 | 44 | |
| 4 | 2018 | 20 | |
| 5 | 2017 | 5 | |
| 6 | Enhancing Two-stage Collaborative Exams by Incorporating Immediate Feedback | 2017 | 1 |
| 7 | 2017 | 285 | |
| 8 | 2017 | 22 | |
| 9 | 2016 | 40 | |
| 10 | 2016 | 5 | |
| 11 | 2015 | 28 | |
| 12 | 2015 | 12 | |
| 13 | 2014 | 34 | |
| 14 | 2014 | 17 | |
| 15 | 2014 | 59 | |
| 16 | 2014 | 9 | |
| 17 | 2014 | 6 | |
| 18 | 2014 | 11 | |
| 19 | 2013 | 195 | |
| 20 | 2009 | 42 |
About Jason De Melo
Jason De Melo is a scholar working on Cancer Research, Molecular Biology and Modeling and Simulation, having authored 20 papers that have together received 854 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Prostate Cancer Treatment and Research (3 papers), Renal and related cancers (2 papers), Protein Degradation and Inhibitors (2 papers), Cancer Cells and Metastasis (2 papers) and Hippo pathway signaling and YAP/TAZ (2 papers). The work is most often cited by research in Cancer Research (311 citations), Molecular Biology (658 citations) and Oncology (231 citations). Jason De Melo has collaborated with scholars based in Canada, United States and China. Frequent co-authors include Damu Tang, Nicholas Wong, Corey Lourenco, Linda Z. Penn, Manpreet Kalkat, Diana Resetca, William B. Tu, Judy Yan, Jean‐Claude Cutz and Tariq Aziz. Their work appears in journals such as Nature Communications, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.